Overview
Distal deletion 9p syndrome (also known as 9p minus syndrome, monosomy 9p, or partial deletion of the short arm of chromosome 9) is a rare chromosomal disorder caused by the loss of genetic material from the distal (far end) portion of the short arm of chromosome 9. The critical region most commonly deleted involves band 9p22-p24, and the size of the deletion can vary among affected individuals, contributing to a spectrum of clinical severity. The condition affects multiple body systems. Key clinical features include intellectual disability of variable degree, characteristic craniofacial dysmorphism (trigonocephaly or metopic ridging, flat nasal bridge, long philtrum, midface hypoplasia, upslanting palpebral fissures, and anteverted nares), and genital anomalies, particularly in males, which may include hypospadias, cryptorchidism, and in some cases ambiguous genitalia or 46,XY disorders of sex development. Cardiac malformations, inguinal hernias, and hypotonia may also be present. Some individuals exhibit behavioral difficulties and speech delay. There is no cure for distal deletion 9p syndrome. Management is supportive and multidisciplinary, tailored to the individual's specific clinical manifestations. This may include early intervention programs, speech and occupational therapy, surgical correction of cardiac or genital anomalies, and ongoing developmental and educational support. Genetic counseling is recommended for affected families to assess recurrence risk, particularly when the deletion arises from a balanced parental chromosomal rearrangement.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
1 eventData sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Distal deletion 9p syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Distal deletion 9p syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Distal deletion 9p syndrome.
Community
No community posts yet. Be the first to share your experience with Distal deletion 9p syndrome.
Start the conversation →Latest news about Distal deletion 9p syndrome
Disease timeline:
New recruiting trial: Chromosome 9 P Minus Syndrome
A new clinical trial is recruiting patients for Distal deletion 9p syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Distal deletion 9p syndrome
What is Distal deletion 9p syndrome?
Distal deletion 9p syndrome (also known as 9p minus syndrome, monosomy 9p, or partial deletion of the short arm of chromosome 9) is a rare chromosomal disorder caused by the loss of genetic material from the distal (far end) portion of the short arm of chromosome 9. The critical region most commonly deleted involves band 9p22-p24, and the size of the deletion can vary among affected individuals, contributing to a spectrum of clinical severity. The condition affects multiple body systems. Key clinical features include intellectual disability of variable degree, characteristic craniofacial dysm
At what age does Distal deletion 9p syndrome typically begin?
Typical onset of Distal deletion 9p syndrome is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Distal deletion 9p syndrome?
1 specialists and care centers treating Distal deletion 9p syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.